1-3 of 3
Philomena Casey
Close
Sort by
Journal Articles

Efficacy and Safety Of Pomalidomide Plus Low-Dose Dexamethasone In Advanced Multiple Myeloma: Results Of Randomized Phase 2 and 3 Trials (MM-002/MM-003)

David S. Siegel, MD, PhD, Paul G. Richardson, MD, Meletios A. Dimopoulos, MD, Christine I. Chen, MD, Kevin Song, MD, Ravi Vij, MBBS, MD, Nizar J. Bahlis, MD, Rachid Baz, MD, Craig C Hofmeister, MD, Katja Weisel, MD, Sundar Jagannath, MD, Sagar Lonial, M.D., Michel Delforge, MD, PhD, Moshe Talpaz, MD, Philippe Moreau, MD, Jesus F San Miguel, MD, PhD, Lionel Karlin, MD, Hartmut Goldschmidt, MD, Anne Banos, MD, Albert Oriol, MD, Adrian Alegre, MD, Laurent Garderet, MD, Michele Cavo, MD, Valentina L Ivanova, MD, PhD, Joaquin Martinez-Lopez, Martha Q Lacy, MD, Min Chen, PhD, Philomena Casey, Lars Sternas, MD, Mohamed H. Zaki, MD, Christian J. Jacques, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2013) 122 (21): 3185.
https://doi.org/10.1182/blood.V122.21.3185.3185
Published: 2013
Journal Articles

Efficacy and Safety of the Combination of Genasense™ (Oblimersen Sodium, Bcl-2 Antisense Oligonucleotide), Fludarabine and Rituximab in Previously Treated and Untreated Subjects with Chronic Lymphocytic Leukemia.

Blanche Mavromatis, MD, Kanti R. Rai, MD, Paul K. Wallace, PhD, Claudia Soho, OCN, Beverly Landrigan, RN, Patricia Meyn, RN, Tracey Wei, MS, Kenneth K. Chan, PhD, Philomena Casey, MS, Steven C. Novick, MD, PhD, Asher A. Chanan-Khan, MD
Journal: Blood
Blood (2005) 106 (11): 2129.
https://doi.org/10.1182/blood.V106.11.2129.2129
Published: 2005
Journal Articles

A Pilot Study of Genasense® (Oblimersen Sodium, Bcl-2 Antisense Oligonucleotide), Fludarabine and Rituximab in Previously Treated and Untreated Subjects with Chronic Lymphocytic Leukemia.

Asher Alban Chanan-Khan, MD, Blanche Mavromatis, MD, Kanti R. Rai, MD, Philomena Casey, Steven Novick, MD, Loretta M. Itri, MD
Journal: Blood
Blood (2004) 104 (11): 4827.
https://doi.org/10.1182/blood.V104.11.4827.4827
Published: 2004